0001375151-19-000007.txt : 20190214
0001375151-19-000007.hdr.sgml : 20190214
20190214204100
ACCESSION NUMBER: 0001375151-19-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190212
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARNER CAM L
CENTRAL INDEX KEY: 0001024007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19609519
MAIL ADDRESS:
STREET 1: PO BOX 675866
CITY: RANCHO SANTE FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155019484594974.xml
FORM 4
X0306
4
2019-02-12
0
0001375151
ZOGENIX, INC.
ZGNX
0001024007
GARNER CAM L
C/O ZOGENIX, INC.
5858 HORTON STREET, SUITE 455
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2019-02-12
4
M
0
218
32
A
218
D
Common Stock
2019-02-12
4
M
0
1562
30.96
A
1780
D
Common Stock
2019-02-12
4
M
0
6250
15.04
A
8030
D
Common Stock
2019-02-12
4
M
0
4375
14.88
A
12405
D
Common Stock
2019-02-12
4
S
0
12405
46.8478
D
0
D
Common Stock
40843
I
By Garner Investments, LLC
Stock Option (Right to Buy)
32.0
2019-02-12
4
M
0
218
0
D
2020-05-29
Common Stock
218.0
0
D
Stock Option (Right to Buy)
30.96
2019-02-12
4
M
0
1562
0
D
2021-05-23
Common Stock
1562.0
0
D
Stock Option (Right to Buy)
15.04
2019-02-12
4
M
0
6250
0
D
2022-04-26
Common Stock
6250.0
0
D
Stock Option (Right to Buy)
14.88
2019-02-12
4
M
0
4375
0
D
2022-06-05
Common Stock
4375.0
0
D
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $46.31 to $47.19, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person is the managing member of Garner Investments, LLC.
The Option was granted on May 30, 2010 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The Option was granted on May 24, 2011 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The Option was granted on April 27, 2012 and vests in a series of thirty-six (36) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
The Option was granted on June 6, 2012 and vests in a series of twelve (12) successive, equal monthly installments beginning on the date of grant, subject to the Reporting Person's continued service to the Company on each vesting date.
/s/ Thomas Doyle, Attorney-in-fact for Cam L. Garner
2019-02-14